Cancer Conference Update
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:46:28
- Mas informaciones
Informações:
Sinopsis
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. CME information and select publications here
